Metrics to compare | QSI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipQSIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.4x | −8.9x | −0.2x | |
PEG Ratio | −0.10 | −0.49 | 0.00 | |
Price/Book | 1.8x | 5.7x | 2.6x | |
Price / LTM Sales | 230.1x | 5.6x | 2.8x | |
Upside (Analyst Target) | 71.7% | 14.7% | 64.8% | |
Fair Value Upside | Unlock | −9.8% | 9.7% | Unlock |
Quantum-Si incorporated, a life sciences company, develops proprietary, universal, and single-molecule detection platform applied to proteomics to enable next-gen protein sequencing (NGPS). The company offers Platinum and Platinum Pro NGPS instruments for single-molecule, amino acid level resolution, and automated data analysis; library preparation kits to prepare a customer’s protein sample for sequencing; and sequencing kits, which contain the reagents and consumables used to perform NGPS. It also provides Platinum analysis software, a cloud-based solution that automates data analysis workflows and visualizes the sequencing results. The company was founded in 2013 and is headquartered in Branford, Connecticut.